Status:

COMPLETED

Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure

Lead Sponsor:

Josko Bozic

Collaborating Sponsors:

University of Split, School of Medicine

Conditions:

Heart Failure,Congestive

Eligibility:

All Genders

35-90 years

Brief Summary

The congestive heart failure (HF) is a condition associated with substantial morbidity, mortality, and high healthcare expenditures. From the pathophysiological standpoint, several mechanisms contribu...

Eligibility Criteria

Inclusion

  • Healthy adult men and women, 35-90 years of age
  • Patients with clinically documented diagnosis of congestive heart failure (CHF) according to New York Heart Association (NYHA) functional classification (II-IV)

Exclusion

  • Age criteria:
  • Persons below legal age (\<18 years)
  • Adults younger than 35 years of age
  • Adults older than 90 years of age
  • Participants with following conditions:
  • Diabetes mellitus type I
  • Documented or newly-established severe valvular or pericardial disease
  • Infiltrative or hypertrophic cardiomyopathy
  • Primary pulmonary disease or cor pulmonale
  • Active malignant disease and/or active infectious disease
  • Significant systemic autoimmune disease
  • A positive history of excessive alcohol, drug, narcotics, and sedative consumption
  • Significant psychiatric or neurologic condition
  • Immunocompromised patients or patients that are under immunosuppressive treatment
  • Significant liver or renal insufficiency (primary renal or hepatic disease)
  • Hemorrhagic diathesis or significant coagulopathy
  • Positive recent history of cancer chemotherapeutic drug use
  • A positive history of acute coronary syndrome or stroke within 3 months prior to study enrollment

Key Trial Info

Start Date :

January 25 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 16 2019

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT03389386

Start Date

January 25 2018

End Date

April 16 2019

Last Update

April 17 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospital of Split

Split, Split-Dalmatia County, Croatia, 21000

Serum Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure | DecenTrialz